Back to Screener

Healthcare

VSee Health, Inc.(VSEE)

Live Price

Offline

$0.116

-5.69% today

1Y Change

-87.32%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
โ€”
Revenue Growth
+40.3%
EPS Growth
+87.1%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

VSee Health, Inc. (VSEE) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.12 and down 87.3% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of +40.3%, EPS growth of +87.1%, a dividend yield of 0.0%. What stands out right now is revenue +40.3%, EPS +87.1%, free cash flow +40.5% with operating margin -65.6% and ROIC -119.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines VSEE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+40.3% vs +7.6% peer median

Operating Margin

Below sector median

-65.6% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report landed above expectations

2026 was reported on May 15, 2026 with an EPS surprise of +54.5% and a revenue surprise of -34.2%.

The operating story is still moving forward

Revenue is running at +40.3% and EPS at +87.1%, with operating margin around -65.6%.

The next real check-in already has a date

The next earnings event is scheduled for Sep 28, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -12.1% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 15, 2026
+54.5%-11.8%-10.1%โ€”
2026
Mar 31, 2026
-287.5%-5.2%-6.4%-26.0%
2025
Nov 14, 2025
+75.0%-5.5%-19.7%-36.7%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

VSEE

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

VSEE Max Drawdown

-90.21%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for VSEE and SPY.

Calendar-year return history is still loading or unavailable.
VSee Health, Inc. logo

Company Overview

VSee Health, Inc.

NASDAQ Capital Market

VSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.

Leadership
Milton Chen
IPO Date
Dec 31, 2021
Employees
2
Street Address
One Gateway Center
Mailing
Newton, MA, 02458
Region
Newton, MA, US
Reporting Currency
USD
Investor Line
+1 650 618 0245
Last Updated
May 5, 2026
CIK: 0001864531ISIN: US92919Y1029
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
0.2
Price/Book
0.7

Growth

Revenue
+40.3%
EPS
+87.1%
Free Cash Flow
+40.5%

Profitability

Gross Margin
50.3%
Operating Margin
-65.6%
Net Margin
-100.6%
ROE
629.0%
ROIC
-119.7%

Balance Sheet

Debt/Equity
0.45
Current Ratio
0.51

Earnings Reports

๐Ÿ“… Next earningsSep 28, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Sep 28, 26
TBD
โ€”
Est -0.06
โ€”
โ€”
Est 5200.0B
โ€”
โ€”
May 15, 26
โœ“
-0.05
Est -0.11
+54.5%
3160.2B
Est 4800.0B
-34.2%
โ€”
Mar 31, 26
โœ—
-0.31
Est -0.08
-287.5%
3925.9B
Est 4400.0B
-10.8%
โ€”
Nov 14, 25
โœ“
-0.02
Est -0.08
+75.0%
3980.7B
Est 4200.0B
-5.2%
โ€”
Oct 15, 25
โœ—
-0.14
Est -0.12
-16.7%
3390.1B
Est 3900.0B
-13.1%
โ€”
Aug 28, 25
โœ—
-0.36
Est -0.09
-295.1%
3859.4B
Est 3500.0B
+10.3%
โ€”
Nov 14, 24
-0.81
Est โ€”
โ€”
3354.4B
Est โ€”
โ€”
โ€”
Sep 23, 24
-0.06
Est โ€”
โ€”
1711.6B
Est โ€”
โ€”
โ€”
May 14, 24
-0.00
Est โ€”
โ€”
1496.0B
Est โ€”
โ€”
โ€”
Apr 12, 24
-0.28
Est โ€”
โ€”
1427.9B
Est โ€”
โ€”
โ€”
Nov 21, 23
-0.01
Est โ€”
โ€”
1451.5B
Est โ€”
โ€”
โ€”
Aug 22, 23
-0.09
Est โ€”
โ€”
1290.2B
Est โ€”
โ€”
โ€”
May 16, 23
-0.05
Est โ€”
โ€”
1596.3B
Est โ€”
โ€”
โ€”
Apr 12, 23
-0.05
Est โ€”
โ€”
1529.8B
Est โ€”
โ€”
โ€”
Nov 11, 22
-0.03
Est โ€”
โ€”
1498.0B
Est โ€”
โ€”
โ€”
Oct 12, 22
-0.03
Est โ€”
โ€”
1576.3B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.